WASHINGTON, D.C. – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, issued the following statement after the House of Representatives passed H.R. 2483, the SUPPORT for Patients and Communities Reauthorization Act, by a vote of 366 to 57.

“After several years of bipartisan collaboration on the SUPPORT Act, the House of Representatives passed legislation to continue fighting the fentanyl crisis by improving access to treatment, expanding recovery opportunities, and bolstering prevention initiatives,” said Chairman Guthrie. “The programs within the SUPPORT Act have made significant steps toward reducing the toll illicit fentanyl and fentanyl-related substances take on our communities. By reauthorizing this important legislation, we are increasing prevention initiatives, reducing drug-related deaths, and restoring hope for families. I thank my colleagues for their bipartisan commitment to saving lives.”

Background:

In 2018, President Trump signed into law the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act in response to the opioid epidemic that has ravaged communities across the country, particularly those in rural areas.

H.R. 2483, the SUPPORT for Patients and Communities Reauthorization Act of 2025, was reported to the full House from the Committee on Energy and Commerce by a roll call vote of 36 yeas – 13 nays.

The SUPPORT Act:

·      Ensures first responders can access and administer naloxone;

·      Allows for enhanced SUD treatment options for pregnant and postpartum women;

·      Strengthens state PDMP systems;

·       Encourages individuals in recovery to participate in the workforce; and

·       Continues the supply of resources for Comprehensive Opioid Recovery Centers, which provide a full spectrum of treatment and recovery support services.

###